1. Teva progress towards first milestone, and application inside Brazil , first royalties. 2. Aus zolpi marketing application (Jan timeline), 3. Eddy and the CFDA application, 4. Update on Europe and South America zolpi negotiations, 5. Anagrelide update on plans (and progress) moving forward, 6. Co-Development update on all opportunities in the pipeline, 7. Reconfirming Artimist TGA and trade sale timelines 8. Update on 001 and 002 negotiations.
keep news ticking over.
SUD Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held